An interventional study of Quadratus Lumborum Block type 2 and Transversalis Fascia Plane Block in Analgesia, Donor Nephrectomy and Postoperative Pain, sponsored by Koc University Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 84 Years. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Koc University Hospital · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,107 studies in Pain, Postoperative with a site in Turkey — 266 open to participants now, 300 under way, none of them phase 3. Pain, Postoperative · Turkey.
Among the 1,107 studies in Pain, Postoperative with a site in Turkey, this one is the 716th largest by planned enrollment of the 892 interventional ones that give a count, is one of 228 that started in 2026, is one of 823 with no phase, reaches primary completion later than 237 of the 299 other live ones, and was the 1,058th registered.
5,675 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →266 of the 1,107 studies in Pain, Postoperative with a site in Turkey are open now. Recruiting first, the newest first:
Ankara Etlik City Hospital · Sites in Turkey
Ages 50–80 · Men only
Marmara University Pendik Training and Research Hospital · Sites in Turkey
Ages 18–75 · Men only
Konya City Hospital · Sites in Turkey
Ages 18–65
Kocaeli City Hospital · Sites in Turkey
Ages 8–18 · Healthy volunteers
Bursa City Hospital · Sites in Turkey
Ages 18–85 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 84 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,107 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 4 · Phase 3 2 · Phase 4 59
First in 2009; this study’s year is marked. 228 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 54 is below the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 70 across the 892 interventional studies, 80 across the 215 observational. Of the 756 that completed or were terminated, 9 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 1,107 have an industry lead sponsor. The 10 most frequent:
Koc University Hospital is the lead sponsor of 11 studies on the registry; 3 are open to participants now.
Koc University Hospital has 4 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
140 of the studies in Pain, Postoperative with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07659990Ferit YetikRISS Versus SPSIP Block in Modified Radical Mastectomy | 2026-11 |
| NCT07524673Cumhuriyet UniversityComprasion of SPSIP and Rhomboid Intercostal Plan Blocks on VATS | 2026-11 |
| NCT06869967Kocaeli UniversityEvaluation of Postoperative Pain Control in Ear Surgery | 2026-11-25 |
| NCT07274995Başakşehir Çam & Sakura City HospitalMachine Learning-Based Prediction of Postoperative Pain After Pediatric Ambulatory Surgery | 2026-11-30 |
| NCT07915804Istanbul UniversityPerfusion Index for Postoperative Pain Assessment in Pediatric Adenotonsillectomy | 2026-11-30 |
Add all 140 to your calendar (.ics) → With an account.
Among the 1,107 studies in Pain, Postoperative with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective randomized non-inferiority trial is designed to compare postoperative analgesic effect of transversalis fascia plane block and posterior quadratus lumborum block in hand assisted laparoscopic donor nephrectomy. Posoperative opioid consumption, numeric rating scale pain scores and adverse effects will be assessed during the trial.
Hand-assisted laparoscopic donor nephrectomy (HALDN) is a widely used technique for kidney donor surgeries. Management of postoperative pain is important to provide patient comfort. Main components of postoperative pain is from incision sides. Regional anesthesia techniques may reduce postoperative opioid requirements in this patient group, but the optimal block for this procedure has not been established.
A competed but not yet published study in our clinic found that transversalis fascia plane block significantly reduced analgesic requirements after HALDN. Its a deep block, that involves injection below transversalis fascia and above perirenal fat tissue. Its location can be seen relatively close to the important structures of such as peritoneum and retroperitenoum. Posterior quadratus lumborum block (PQLB, also known as quadratus lumborum block -2 or QLB-2) is considered effective in renal surgery for other indications and PQLB may provide analgesia comparable to TFPB for HALDN surgery. Possible benefit of PQLB over TFPB is superficial anatomical location of PQLB and its relative distance to areas such as retroperitoneum and peritoneum. Results in our center shows TFPB effective in HALDN procedure, therefore it is selected as the control group intervention This trial is designed to determine whether PQLB is not inferior to TFPB for cumulative opioid consumption during the first 24 postoperative hours for HALDN surgery. Opioid consumption, pain scores and adverse effects through first 48 hours postoperatively and patient satisfaction at 48th hour will be evaluated as a secondary outcome to describe the duration of postoperative analgesic effect.
Routine preanesthetic premedication with midazolam 0.03 mg/kg will be administered to both study groups. Anesthesia will be induced with fentanyl 1-2 micrograms/kg IV, propofol 1-2 mg/kg IV, and rocuronium 0.9-1.2 mg/kg IV.
General anesthesia will be maintained with 40% inspired oxygen, desflurane at approximately 1 minimum alveolar concentration, and a remifentanil infusion at 0 - 0.02 micrograms/kg/min. The actual doses of all intraoperative opioids will be recorded. Intraoperative fentanyl and remifentanil administered before the end of surgery will not be included in the primary outcome.
The assigned block will be performed after induction of general anesthesia and before surgical incision, with the participant in the lateral position and the operative side facing upward.
Standard anesthesia monitoring will continue throughout block placement and until the surgery ends.
At the end of surgery, all participants will receive paracetamol 1 g IV and morphine 0.05 mg/kg IV in addition to regional anesthesia technique as standardized multimodal analgesia regiment. The end-of-surgery morphine dose will be included in cumulative postoperative opioid consumption.
Participants will be extubated in the operation room when clinically appropriate and transferred to the post-anesthesia care unit.
In the PACU, a morphine PCA device will be started using a 1 mg IV bolus, an 8-minute lockout interval, and no basal infusion. Device-generated records will be used to determine PCA consumption. In PACU, if NRS is greater than or equal to 4 is observed, fentanyl 50 micrograms IV will be administered up to three times at 15-minute intervals. All fentanyl administered in the PACU will be included in cumulative postoperative opioid consumption.
For 48 hours, all participants will receive paracetamol 1 g IV three times daily and morphine PCA using the same settings. In surgical ward, If NRS is greater than or equal to 4 is observed, tramadol 100 mg IV will be administered as rescue analgesia in accordance with institutional prescribing limits.
Every rescue dose and any additional analgesic treatment required for clinical care will be recorded. Tramadol will be converted to IV morphine equivalents and included in cumulative postoperative opioid consumption.
Morphine PCA cumulative consumption, rescue opioid and analgesic use, NRS at rest, NRS during cough, and opioid-related and block-related adverse events will be assessed at postoperative hours 1, 3, 6, 12, 24, and 48.
Patient satisfaction with postoperative pain management will be assessed at postoperative hour 48.
Protocol deviations, withdrawal, loss to follow-up, unblinding, and missing assessments will be recorded whenever they occur.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Posterior quadratus lumborum block will be administered by the senior anesthesiologist, following the anesthesia induction and before the surgical incision.
Procedure: Quadratus Lumborum Block type 2
Transversalis fascia plane block will be administered by the senior anesthesiologist, following the anesthesia induction and before the surgical incision.
Procedure: Transversalis Fascia Plane Block
Posterior Quadratus Lumborum Block Technique A 2-6 MHz convex ultrasound probe will be positioned parallel to and over the iliac crest. Anterior and posterior scanning will identify the quadratus lumborum, psoas major, transversus abdominis, external and internal oblique muscles, lumbar vertebral body and transverse process, and perirenal adipose tissue. An 80-mm Stimuplex needle will be advanced in-plane under continuous ultrasound visualization. After negative aspiration, 30 mL of 0.25% bupivacaine will be injected into the posterior fascial plane of the quadratus lumborum muscle. Spread of the solution will be observed continuously using ultrasound, with repeated aspiration during injection.
Also known as: QLB-2, PQLB, Posterior quadratus lumborum block
Transversalis fascia plane block administration technique: A 2-6 MHz convex ultrasound probe will be positioned parallel to and over the iliac crest. Anterior and posterior scanning will identify the quadratus lumborum, psoas major, transversus abdominis, external and internal oblique muscles, lumbar vertebral body and transverse process, and perirenal adipose tissue. An 80-mm Stimuplex needle will be advanced in-plane under continuous ultrasound visualization. After negative aspiration, 30 mL of 0.25% bupivacaine will be injected over the perirenal adipose tissue beneath the transversus abdominis fascia. Spread of the solution will be observed continuously using ultrasound, with repeated aspiration during injection to reduce the risk of intravascular administration.
Also known as: TFPB
Postoperative opioid consumption for 24 hours
The primary outcome is cumulative opioid consumption from the end of surgery through postoperative hour 24, expressed as IV morphine equivalents. Postoperative opioids will be converted to IV morphine equivalents using the ENCORE Study conversion table. The following conversion factors will be used: IV fentanyl: dose in micrograms × 0.066 = IV morphine equivalents in mg. IV tramadol: dose in mg × 0.1 = IV morphine equivalents in mg.
Time frame: postoperative 24 hours
postoperative opioid consumption for 48 hours
Cumulative opioid consumption from the end of surgery through postoperative hour 48, expressed as IV morphine equivalents. Assesment will be made at postoperative 1,3,6,12,24 and 48th hour. Postoperative opioids will be converted to IV morphine equivalents using the ENCORE Study conversion table. The following conversion factors will be used: IV fentanyl: dose in micrograms × 0.066 = IV morphine equivalents in mg. IV tramadol: dose in mg × 0.1 = IV morphine equivalents in mg.
Time frame: postoperative 48 hours
pain score
Pain will be assesed by NRS scores at rest and cough, expressed drom 0 to 10. Assesment will be made at postoperative 1,3,6,12,24 and 48th hour.
Time frame: postoperative 48 hours
adverse effects
Incidence and details of nausea, vomiting, pruritus, allergic reaction, sedation, respiratory depression, urinary retention, LAST, bleeding or hematoma, infection, persistent sensory or motor deficit, nerve injury, visceral or renal injury, and any other opioid or block-related adverse event through 48 hours.
Time frame: postoperative 48 hours
patient satisfaction
6\. Patient satisfaction at 48 hours, assessed by asking: "How satisfied were you with your postoperative pain management?" The response will range from 0 to 10.
Time frame: postoperative 48 hours
Plan to share: No
Start is estimated for Oct 2026; primary completion for Apr 2027, 6 months later.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 6 months is below that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Koc University Hospital